Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Veeva Systems Acquires AdvantageMS

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
Acquisition enhances Veeva Network – a complete, cloud-based customer master solution.

Following Veeva Systems’ recent unveiling of Veeva Network, the life sciences industry’s first cloud-based customer master solution, the company has acquired national healthcare data provider, AdvantageMS. The acquisition adds a database of more than seven million active healthcare providers (HCPs), healthcare organizations (HCOs) and affiliations across the United States to Veeva Network. This acquired data, combined with Veeva’s advanced cloud software and data stewardship services, provides life sciences companies with an accurate, up-to-date view of their customers in one solution.

Historically, life sciences organizations have struggled to stitch together sets of non-standardized data from a myriad of sources. Generating a single source of the truth about customers that’s accurate, kept up-to-date and accessible to users has proven to be expensive, time consuming and yet still elusive for most. With Veeva’s acquisition of AdvantageMS, Veeva Network will provide pharmaceutical companies with accurate information on their customers without the complicated patchwork of systems, data and staff. Additionally, Veeva Network is integrated with Veeva CRM, so data is fully accessible to sales and marketing users for improved efficiency.

“AdvantageMS is an organization of great people and their data is one of the most reliable sources of U.S. healthcare data, trusted by life sciences organizations of all sizes for over a decade,” said Peter Gassner, president and CEO of Veeva Systems. “We are thrilled to have AdvantageMS join the Veeva team.”

AdvantageMS also provides Veeva Network with data compliance services and one of the most detailed HCP email lists available, with over 500,000 verified records. The database is 100% permission-based and contains workplace email addresses, including hard-to-find group practice and hospital-based emails. As a result, life sciences companies will be able to reliably extend their digital outreach programs.

“Like AdvantageMS, Veeva is dedicated to customer success. By combining our data and services with the Veeva Network application we will deliver exceptional value to our joint customers,” explained Richard Johnston, CEO of AdvantageMS.

AdvantageMS customers will continue to receive existing data services, while joint Veeva and AdvantageMS customers will be able to benefit from the strategic acquisition through Veeva Network – planned for general availability throughout the United States and China in late 2013, with other markets to follow.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!